Chapter 54: Subtype selective muscarinic agonists: potential therapeutic agents for Alzheimer's disease
- 1 January 1993
- book chapter
- Published by Elsevier
- Vol. 98, 439-445
- https://doi.org/10.1016/s0079-6123(08)62430-9
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Childhood cerebellar hemangioblastoma does not predict germline or somatic mutations in the von Hippel-Lindau tumor suppressor gene.Annals of Neurology, 2002
- Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodiesJournal of Neuroscience, 1991
- No response to high‐dose muscarinic agonist therapy in Alzheimer's diseaseNeurology, 1988
- Identification of a Family of Muscarinic Acetylcholine Receptor GenesScience, 1987
- Induction of depression with oxotremorine in patients with Alzheimer's diseaseAmerican Journal of Psychiatry, 1987
- Muscarinic Agonist Therapy of Alzheimer's DiseaseArchives of Neurology, 1986
- Effects of Cholinergic Enhancement Therapies on Memory Function in Alzheimer's Disease: A Meta-Analysis of the LiteratureAustralian & New Zealand Journal of Psychiatry, 1986
- Measurement of cholinergic drug effects on memory in alzheimer's diseaseNeurobiology of Aging, 1983
- Physostigmine and Arecoline: Effects of Intravenous Infusions in Alzheimer Presenile DementiaThe British Journal of Psychiatry, 1981
- SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASEPublished by Elsevier ,1976